Relmada Therapeutics Inc banner

Relmada Therapeutics Inc
NASDAQ:RLMD

Watchlist Manager
Relmada Therapeutics Inc Logo
Relmada Therapeutics Inc
NASDAQ:RLMD
Watchlist
Price: 7.17 USD 61.12% Market Closed
Market Cap: $525.8m

Intrinsic Value

The intrinsic value of one RLMD stock under the Base Case scenario is 0.19 USD. Compared to the current market price of 7.17 USD, Relmada Therapeutics Inc is Overvalued by 97%.

RLMD Intrinsic Value
0.19 USD
Overvaluation 97%
Intrinsic Value
Price
Base Case Scenario

Valuation History
Relmada Therapeutics Inc

What is Valuation History?
Ask AI Assistant
What other research platforms think about RLMD?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is RLMD valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Relmada Therapeutics Inc.

Explain Valuation
Alternatives to RLMD

Wall St
Price Targets

Dividends

Relmada Therapeutics Inc
does not pay dividends
Shareholder Yield

Competitive Landscape

Ownership

RLMD Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one RLMD stock?

The intrinsic value of one RLMD stock under the Base Case scenario is 0.19 USD.

Is RLMD stock undervalued or overvalued?

Compared to the current market price of 7.17 USD, Relmada Therapeutics Inc is Overvalued by 97%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett